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ABSTRACT Toxoplasma gondii’s single mitochondrion is very dynamic and under-
goes morphological changes throughout the parasite’s life cycle. During parasite di-
vision, the mitochondrion elongates, enters the daughter cells just prior to cytokine-
sis, and undergoes fission. Extensive morphological changes also occur as the
parasite transitions from the intracellular environment to the extracellular environ-
ment. We show that treatment with the ionophore monensin causes reversible con-
striction of the mitochondrial outer membrane and that this effect depends on the
function of the fission-related protein Fis1. We also observed that mislocalization of
the endogenous Fis1 causes a dominant-negative effect that affects the morphology
of the mitochondrion. As this suggests that Fis1 interacts with proteins critical for
maintenance of mitochondrial structure, we performed various protein interaction
trap screens. In this manner, we identified a novel outer mitochondrial membrane
protein, LMF1, which is essential for positioning of the mitochondrion in intracellular
parasites. Normally, while inside a host cell, the parasite mitochondrion is main-
tained in a lasso shape that stretches around the parasite periphery where it has re-
gions of coupling with the parasite pellicle, suggesting the presence of membrane
contact sites. In intracellular parasites lacking LMF1, the mitochondrion is retracted
away from the pellicle and instead is collapsed, as normally seen only in extracellular
parasites. We show that this phenotype is associated with defects in parasite fitness and
mitochondrial segregation. Thus, LMF1 is necessary for mitochondrial association with
the parasite pellicle during intracellular growth, and proper mitochondrial morphology is
a prerequisite for mitochondrial division.
IMPORTANCE Toxoplasma gondii is an opportunistic pathogen that can cause dev-
astating tissue damage in the immunocompromised and congenitally infected. Cur-
rent therapies are not effective against all life stages of the parasite, and many
cause toxic effects. The single mitochondrion of this parasite is a validated drug tar-
get, and it changes its shape throughout its life cycle. When the parasite is inside a
cell, the mitochondrion adopts a lasso shape that lies in close proximity to the pelli-
cle. The functional significance of this morphology is not understood and the pro-
teins involved are currently not known. We have identified a protein that is required
for proper mitochondrial positioning at the periphery and that likely plays a role in
tethering this organelle. Loss of this protein results in dramatic changes to the mito-
chondrial morphology and significant parasite division and propagation defects. Our
results give important insight into the molecular mechanisms regulating mitochon-
drial morphology.
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Toxoplasma gondii is an opportunistic protozoan parasite that can infect nearly anynucleated cell in a wide range of warm-blooded organisms. This promiscuity
contributes to T. gondii being one of the most widespread and successful parasites in
the world. It has been estimated that approximately one-third of the world’s human
population is infected with Toxoplasma (1). While infections in otherwise healthy adults
are asymptomatic, in immunocompromised individuals and lymphoma patients, infec-
tions can lead to toxoplasmic encephalitis, among other complications. Additionally, in
congenital infections, toxoplasmosis can lead to blindness, severe neurological prob-
lems, or even death given the immature nature of the fetal immune system. One
interesting feature of Toxoplasma is its single mitochondrion, which is very large and
extends to the periphery of the cell. In addition to its plant-like features, such as tubular
cristae, the Toxoplasma mitochondrion has a streamlined mitochondrial genome con-
sisting of three genes, cox1, cob, and cox3, encoding three proteins (2). These unique
features of the mitochondrion, along with its essentiality for parasite survival, make it
an interesting drug target. The clinical effectiveness of the mitochondrial inhibitor
atovaquone against Toxoplasma and related parasites highlights the validity of this
organelle as a target for antiparasitic therapy (3). Aspects of the apicomplexan mitochon-
drion that remain unexplored as a potential target are its morphology and division. Thus,
in-depth understanding of the regulation of mitochondrial morphology and dynamics in
Toxoplasma could reveal novel therapeutic targets.
The mitochondrion of Toxoplasma is highly dynamic and exhibits significant mor-
phological changes during the parasite’s life cycle and in response to various stressors.
As there is only one mitochondrion per parasite, its division is tightly coordinated with
the division of the rest of the parasite (4). Toxoplasma divides by endodyogeny, a
specialized process through which two daughter cells form within the mother parasite
and during which each organelle is either made de novo or elongated and divided for
incorporation into the daughter parasites. The mitochondrion divides very late in this
process and is not incorporated into the daughter parasites until the parasites have
almost completely emerged from the mother parasite (4). Typically, the mitochondrial
division machinery is made up of three components: a fission protein to recruit proteins
necessary for division, adaptor proteins to provide a scaffold, and a dynamin-related
protein to cause the final scission of the mitochondrion (5). Toxoplasma does not
appear to carry any genes that encode homologs to the adaptor proteins or any of the
additional recruiting proteins found in mammals, such as Mff or Mid49/51 (6). It does
contain genes that encode one homolog of the fission protein Fis1 (TGGT1_263323)
and three potential dynamin-related proteins (Drps): DrpA, DrpB, and DrpC. T. gondii
DrpA (TgDrpA) and TgDrpB have been shown to be required for apicoplast replication
and secretory organelle biogenesis, respectively (7, 8). TgDrpC is divergent from the
typical Drp due to the absence of a conserved GTPase effector domain, which is
generally required for function. We recently showed that TgDrpC localizes to cytoplas-
mic puncta that redistribute to the growing edge of the daughter parasites during
endodyogeny and that it interacts with proteins that exhibit homology to those
involved in vesicle transport (9, 10).
After repeated division cycles, the parasites egress from the cell and are exposed to
the extracellular environment, where the mitochondrion alters its morphology. When
Toxoplasma is within a host cell, it maintains its mitochondrion in a lasso shape that
spans the parasite’s periphery and is adjacent to the parasite pellicle (2, 4, 11).
Immediately after egress, the mitochondrion retracts from the periphery of the parasite
and transitions to a “sperm-like” morphology, where the majority of mitochondrial
material is at the apical end of the parasite with a tail of material extending toward the
basal end (11). Prolonged exposure to the extracellular environment results in transition
to a completely collapsed mitochondrion. Upon reinvasion, the mitochondrion returns
to the “lasso” shape almost immediately (11). Electron microscopy of parasites with
lasso-shaped mitochondrion reveals the presence of regions of close abutment be-
tween the outer mitochondrion membrane (OMM) and the inner membrane complex
(IMC), in which the membranes retain a constant distance over stretches of 100 nm to
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1,000 nm (11). The average distance between the OMM and IMC was calculated to be
approximately 25 nm, which would suggest the presence of membrane contact sites
(11, 12). Neither the functional significance nor the components of the proposed
contact between the mitochondrion and the pellicle are known.
We have also observed that the mitochondrion of Toxoplasma significantly changes
its morphology in response to exposure to the anticoccidial drug monensin. Monensin
is a sodium hydrogen exchanger that induces oxidative stress (13) and autophagic cell
death (14). We demonstrate that monensin’s effect on mitochondrion morphology is
reversible, suggesting that Toxoplasma has mechanisms to rearrange the mitochondrial
structure in response to drug-induced stress. As the mitochondrion appears broken
down upon monensin treatment, we investigated the role of the fission machinery on
this phenomenon. Here, we show that monensin induces a reversible constriction of
the outer mitochondrial membrane and that this effect is in part dependent on the
fission protein Fis1. We also show that, although Fis1 is not required for parasite
survival, mislocalization of Fis1 away from the outer mitochondrial membrane results in
aberrant mitochondrial morphology. We hypothesize that the dominant-negative ef-
fect caused by mislocalization of Fis1 is due to misdirecting critical proteins away from
the mitochondrion. Accordingly, we identified interactors of Fis1. One such interactor,
TGGT1_265180, proved to be required for parasite growth, division, and mitochondrial
segregation. Importantly, the mitochondria of intracellular parasites lacking this Fis1
interactor are not lasso shaped but instead are collapsed away from the parasite
periphery. Accordingly, we hypothesize that this novel protein is part of the proposed
scaffold that mediates membrane contact sites between the mitochondrion and par-
asite pellicle.
RESULTS
Monensin-induced mitochondrial remodeling is reversible. We had previously
observed that treatment with the polyether ionophore monensin induced gross mor-
phological changes in Toxoplasma, including alterations in the Golgi apparatus and
mitochondrion (13). In particular, the mitochondrion, which under normal growth
conditions appears as a lasso along the periphery of the parasite, becomes fragmented
in appearance upon monensin treatment (Fig. 1A). To assess whether this effect on the
parasite mitochondrion was reversible, parasites were treated with either vehicle or
1 mM monensin for 12 h, followed by a 12-h recovery period on normal growth
medium. Under vehicle-treated conditions, parasites exhibited intact mitochondria in
greater than 91% of vacuoles (Fig. 1A and B). In contrast, after 12 h of monensin
treatment, only 6.25% 11.8% of vacuoles contained parasites with intact mitochon-
dria, congruent with previous findings (Fig. 1A and B). Interestingly, this phenotype is
reversed when the drug is removed, and parasites are allowed to recover for 12 h. After
the 12-h recovery period, in 79.5% 5.5% of vacuoles, all parasites show normal
mitochondrial morphology (Fig. 1A and B). Of note, there was no observed reduction
in the total number of parasite-containing vacuoles in the cultures in which the drug
was removed and in culture in which the drug was not removed, indicating a genuine
recovery and not an expansion of surviving parasites.
To determine whether mitochondrial remodeling is a generalized drug response,
parasites were challenged with atovaquone and myxothiazol, both cytochrome bc1
complex inhibitors, and pyrimethamine, a dihydrofolate reductase inhibitor not
known to affect mitochondrial function. After 12 h of atovaquone treatment, only
27.3% 15.5% of parasites showed intact mitochondria, and as observed with monen-
sin, this effect was reversed by the removal of drug and a 12-h drug-free recovery
period (75.8%  13.0% intact mitochondria [Fig. 1C]). In contrast, a lethal dose of
myxothiazol (50 ng/ml [15, 16]) had little effect on mitochondrial morphology, with
82% 5.4% of vacuoles with intact mitochondrion after treatment, which increased to
91.5% 5.2% upon drug removal, although these effects did not meet statistical
significance (Fig. 1C). Upon pyrimethamine treatment, 60.3%  17.0% of parasites had
aberrant mitochondrial morphology. As this level did not change with statistical
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significance upon removal of drug (75.5%  16.2%), the disruption of the mitochon-
drion observed is likely the consequence of parasite death and not the temporary and
reversible rearrangement seen with monensin and atovaquone. Taken together, revers-
ible mitochondrial disruption does not appear to be a generalized mechanism for
responding to stress induced via drug challenge. Moreover, Toxoplasma possesses the
capacity for reversible mitochondrial rearrangement in response to specific drug-
induced stress.
A fission protein homolog localizes to the outer mitochondrial membrane. The
most striking aspect of monensin treatment in Toxoplasma is the disruption of mito-
FIG 1 Drug-induced mitochondrial disruption is reversible. To determine the effects of drugs on
mitochondrial morphology, intracellular parasites were treated with various agents. Parasite mitochon-
drial morphology was examined by visualizing the inner mitochondrial membrane (IMM)-localized F1B
ATPase through immunofluorescence microscopy. (A) Left panels show mitochondrion after treatment
with vehicle, while right panels show effect of treatment with 1 mMmonensin for 12 h. The mitochondria
in the vehicle-treated parasites shown are considered intact, while in the drug-treated parasites shown,
they are considered disrupted. Bars, 2 m. (B) The percentage of vacuoles with intact mitochondria is
presented for parasites that were treated with vehicle (Veh) or with monensin (Mon) for 12 h or treated
with monensin, followed by a 12-h recovery period. (C) The effects of the antiparasitic drug atovaquone
(Ato) (100 nM), pyrimethamine (Pyr) (100 M), and myxothiazol (Myx) (50 ng/ml) on the mitochondrion
were assessed. With each drug we also tested the effect of a 12-h recovery period after 12 h of drug
treatment. For all graphs, 100 vacuoles for each condition were enumerated at random, and the data are
presented as the averages  standard deviations (SD) (error bars) from three independent experiments.
One-way ANOVA with a posthoc Tukey test was utilized for statistical analysis. In panel B, ***, P  0.0001
in comparison to other treatments. In panel C, each drug treatment was compared to vehicle treatment
(****, P  0.0001; **, P  0.007; n.s., not significant), and each treatment was compared to treatment
followed by recovery (####, P  0.001).
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chondrial morphology, producing what appears to be a fragmented organelle. A survey
of the Toxoplasma database (ToxoDB) to identify homologs involved in mitochondrial
dynamics revealed that the genome of Toxoplasma is rather bereft of proteins that
participate in the fusion and fission processes. However, we were able to identify a
protein (TGGT1_263323) with homology to the fission 1 (Fis1) protein from higher
eukaryotes. TGGT1_263323, referred to hereafter as Fis1, is a 154-amino-acid protein
and contains two tetratricopeptide (TPR) domains, a C-terminal transmembrane (TM)
domain, followed by a 3-amino-acid C-terminal sequence (CTS). In previous work
focused on the characterization of membrane anchor domains in Toxoplasma, we
showed through transient transfection of an N-terminal hemagglutinin (HA)-tagged
Fis1 that it localized to the mitochondrion (17). In order to further characterize the
localization and function of Fis1, we established a parasite strain stably expressing an
N-terminally HA epitope-tagged version of Fis1 under the control of the SAG1 promoter
(Fig. 2A). Immunofluorescence assay (IFA) of intracellular parasites of this strain
(RHΔhptHAFis1) confirmed that Fis1 localized to the parasite mitochondrion by
colocalization with F1B ATPase protein, which is located in the inner mitochondrial
membrane (IMM) (Fig. 2B). Superresolution imaging shows that the Fis1 signal envelops
the signal from F1B ATPase (Fig. 2C). This strongly suggests that, as expected for Fis1
proteins, Fis1 localizes to the outer mitochondrial membrane.
Since we had observed mitochondrial fragmentation following monensin treatment,
we next sought to examine whether drug challenge resulted in altered localization of
FIG 2 Fis1 localizes to the Toxoplasma outer mitochondrial membrane, which remains intact after
monensin treatment. To determine the subcellular distribution of the fission protein homolog Fis1, a
parasite strain expressing an ectopic copy of Fis1 including an N-terminal HA epitope tag was generated.
(A) Illustration shows the exogenously expressed epitope-tagged Fis1. Protein domains in Fis1 are
indicated: tetratricopeptide repeat domains TPR1 and TPR2 and transmembrane (TM) domain. (B to D)
Intracellular parasites of the (HA)Fis1-expressing strain were analyzed by IFA using antibodies against the
HA tag to detect Fis1 (in green) and against the Toxoplasma F1B ATPase protein to delineate the inner
mitochondrial membrane (in red) using either a Nikon Eclipse 80i microscope (B) or an OMX 3D-SIM
superresolution imaging system (C and D). (D) Intracellular parasites were treated for 8 h with monensin
(1 ng/ml). White arrowheads in panel D demarcate regions of Fis1 staining without the ATPase signal. Bar,
2 m.
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Fis1. RHΔhptHAFis1 parasites were treated for 8 h with monensin and prepared for
superresolution imaging. As anticipated, we observed fragmented mitochondrial mor-
phology when examining the localization of F1B ATPase (Fig. 2D). Some of the mito-
chondrial fragments were encircled by the Fis1 protein, as one would expect for a
protein in the outer mitochondrion membrane (OMM) (Fig. 2D). Importantly, we also
identified mitochondrial fragments that appeared to be connected by filaments of Fis1
(white arrowheads [Fig. 2D]). These superresolution images revealed that the OMM
remains intact following the 8-h monensin treatment despite the punctate appearance
of the IMM. Thus, the observed effect of monensin treatment on mitochondrial mor-
phology is not a true fragmentation but rather a constriction of the OMM in particular
regions.
The Fis1 transmembrane domain is required for proper localization to the
OMM. Our previous studies have shown that the TM domain of Fis1 is sufficient for
mitochondrial targeting (17). To determine whether the TM is necessary for mitochon-
drial localization, we established a parasite strain expressing an exogenous copy of Fis1
with an N-terminal HA tag and truncated at the C terminus so as to lack the TM and CTS
(Fig. 3A). Intracellular parasites of this strain were costained with antibodies against HA
to detect Fis1ΔTM and against F1B ATPase to visualize the mitochondrion (Fig. 3B). Fis1
lacking the TM appears to be distributed throughout the cytoplasm in a punctate
pattern (Fig. 3B). A similar result was observed when the TM of the endogenous Fis1
was replaced by an HA epitope tag using homologous recombination (Fig. 3C).
Eliminating the TM of the endogenous Fis1 shifted its localization from the mitochon-
drion to the cytoplasm (Fig. 3D). Thus, proper Fis1 localization to the OMM is depen-
dent on its C-terminal transmembrane domain and CTS.
Mitochondrial morphology is altered by the mislocalization of Fis1. When
analyzing the localization of the truncated endogenous Fis1, we noted that the
morphology of the mitochondrion appeared abnormal. Instead of the typical lasso seen
in wild-type parasites (Fig. 1 and 2), the mitochondrion in parasites of the RHΔku80:
Fis1ΔTM strain appeared to contain additional branches as well as unconnected
strands, a phenotype that seemed to increase as the parasites underwent several
rounds of division (Fig. 3D). In the RHΔku80:Fis1ΔTM strain, 60.4%  7.5% of vacuoles
had parasites with atypical mitochondria (i.e., extraneous branches and strands). This is
in contrast to the parental strain in which only 12.7%  3.4% of vacuoles had parasites
with atypical mitochondria (Fig. 3E). These observations suggest that mislocalizing the
endogenous Fis1 alters the typical mitochondrial morphology.
RHku80:Fis1TM parasites are less susceptible to monensin-induced mito-
chondrial disruption. The Fis1 protein in higher eukaryotes is responsible for fission of
stressed and damaged mitochondria in order to maintain a healthy organelle pool.
Thus, we next sought to determine the effect of Fis1 mislocalization in parasites
undergoing monensin drug challenge. Parasites were treated with vehicle or monensin
for 12 h. Cultures were fixed and examined by immunofluorescence microscopy, and
vacuoles with fragmented F1B ATPase signal were tallied. In the absence of treatment,
the percentage of parasites with punctate F1B ATPase staining was statistically similar
for the parental and mutant strains (18.6%  12.4% versus 23.8%  17.2). Following
monensin treatment of parental parasites, an increase from 18.6%  14.8% to
67.6% 10.5% punctate mitochondria was observed for the parental strain (Fig. 4A). In
RHΔku80:Fis1ΔTM parasites, an increase from 23.8% 17.2% to 51.0% 9.3% punctate
mitochondria was recorded after drug challenge (Fig. 4A). The percent increase be-
tween the vehicle- and monensin-treated parasites was determined, and the increase
in punctate mitochondria was statistically greater for the parental parasites than for the
RHΔku80:Fis1ΔTM parasites, 49.0%  6.1% versus 27.2%  9.6, respectively (Fig. 4B).
The phenotypes observed with the RHΔku80:Fis1ΔTM parasites could be due to
either the absence of Fis1 at the mitochondrion or a dominant-negative effect from the
mislocalized truncated protein. To differentiate between these possibilities, we next
sought to determine how genetic ablation of Fis1 would affect the parasite’s ability
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to respond to monensin challenge and undergo mitochondrial remodeling. Em-
ploying the CRISPR/Cas9 system, RHΔhptHAFis1 parasites ectopically expressing
the N-terminally HA epitope-tagged Fis1 were either transfected with a single guide
RNA (sgRNA) that would target both the endogenous and exogenous Fis1 gene or a
sgRNA for the nonessential uracil phosphoribosyltransferase (UPRT) gene as a control.
Parasites were immediately used to infect human foreskin fibroblasts (HFFs) on cover-
slips and grown in culture for 16 h. Infected cultures were then treated with vehicle or
monensin for 12 h. After treatment, parasites were fixed and IFA was performed with
staining for HA to detect Fis1 and F1B ATPase to visualize the mitochondria (see Fig. S1
in the supplemental material). We then compared the mitochondrial morphology in
Fis1 sgRNA-transfected parasites lacking HA signal to that of control sgRNA-transfected
parasites with HA signal. To control for the effects of Cas9, which is fused to green
fluorescent protein (GFP) (18), we analyzed the mitochondrial morphology only in
parasites with nuclear GFP signal. In vehicle-treated parasites, there was no significant
difference between parasites lacking HA-tagged Fis1 expression and parasites trans-
FIG 3 Fis1 localization is dependent on its transmembrane domain. To determine the necessity of the
TM domain for localization of Fis1, we engineered strains in which either an exogenous or the
endogenous Fis1 lacked the transmembrane domain. (A) Schematic of the exogenous HA-FisΔTM. (B)
Parasites expressing HA-FisΔTM were costained for the exogenous Fis1 (in green) and the mitochondrial
F1B ATPase (in red). Bar, 2 m. (C) Schematic of endogenous Fis1 in which TM has been replaced by an
HA epitope (Fis1ΔTM-HA). (D) Intracellular parasites of the strain expressing the truncated Fis1 were
stained with antibodies against the HA tag (green) to detect Fis1ΔTM and antibodies against F1B ATPase
(red) to detect mitochondria. White arrows indicate abnormal appearing mitochondria. Bars, 2 m. (E)
The frequency of Fis1ΔTM-HA-expressing parasites with abnormal mitochondrial morphology (extrane-
ous fragments or branches) was examined and compared to that of the parental Δku80 strain. In three
independent experiments, parasite vacuoles from 15 random fields of view were enumerated, and the
data are presented as percentage of vacuoles with normal mitochondrial morphology  SD. Student’s
t test was employed for determining statistical significance.
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fected with UPRT sgRNA compared to the control parasites still expressing Fis1 (Fig. 4C
and Fig. S1). Interestingly, in contrast to what we observed with mislocalized Fis1,
complete lack of Fis1 did not affect the mitochondrial morphology. Thus, it appears that
Fis1 lacking the TM domain imparts a dominant-negative effect on mitochondrial
morphology.
As expected, monensin treatment of the Cas9/sgRNA-transfected parasites resulted
in an increase in the number of vacuoles containing punctate F1B ATPase signal.
Control nontransfected parasites and those transfected with the UPRT sgRNA pos-
sessed 83.3%  12.8% and 88.8%  7.7% punctate mitochondria, respectively (Fig. 4C).
However, parasites lacking the HA-tagged Fis1 signal displayed significantly fewer
vacuoles with disrupted mitochondria upon monensin treatment, comprising only
50.5%  16.9% of the vacuoles (Fig. 4C). The percent increase in the number of
vacuoles with punctate mitochondria for the parasites deficient in HA-tagged Fis1
FIG 4 Disrupting Fis1 reduces monensin-induced mitochondrial remodeling. The ability of monensin to
induce mitochondrial remodeling was assessed in strains expressing a mislocalized Fis1 or lacking Fis1.
(A) Parasites in which the endogenous Fis1 lacks the TM domain were treated with vehicle or monensin
for 12 h. Parasite vacuoles were enumerated from 10 random fields of view for each strain and condition.
The data are the averages from four independent experiments and are presented as percentage of
vacuoles with punctate morphology  SD. Statistical analysis was provided by one-way ANOVA posthoc
Tukey test, (**, P  0.001 compared to vehicle; *, P  0.01). (B) Data from panel A were analyzed to
compare the number of vacuoles with punctate mitochondrion in untreated and treated parasites for
each strain. Data are displayed as percent increase of vacuoles with punctate mitochondria upon
treatment  SD. (C) RHΔhpt parasites ectopically expressing the N-terminally HA-tagged Fis1 were
transfected with a plasmid expressing Cas9 and either a Fis1-specific sgRNA or the nonspecific UPRT
sgRNA. After transfection, parasites were immediately infected into HFFs on coverslips. Following
approximately 16 h in culture, cultures were treated with vehicle or monensin for 12 h, and an IFA to
monitor mitochondrial morphology was performed. The data presented are the averages for six
coverslips from two independent transfections. Bars represent percent punctate mitochondria  SD.
Statistical significance was determined via two-way ANOVA, treatment P 0.0.0001, genotype P 0.006,
genotype X treatment P 0.0003. (D) The percent increase in punctate mitochondria between treatment
and no treatment for the data shown in panel C was calculated and presented as averages  SD.
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expression was significantly lower than for either control parasite populations,
23.9%  17% versus 63.3%  16.8% and 77.8%  10.2%, respectively (Fig. 4D). Two-
way analysis of variance (ANOVA) analysis indicated that there was both a treatment
and genotype effect and that the effects interact. Overall, these data indicate that
complete lack of Fis1 does not affect mitochondrial morphology in untreated parasites
but significantly decreases monensin-induced mitochondrial remodeling, indicating
that Fis1 is partially required for constriction of the IMM in response to treatment with
the ionophore.
A putative Fis1 interactor localizes to the OMM. Mislocalization of the endoge-
nous Fis1 results in a dominant-negative phenotype in terms of mitochondrial mor-
phology. We hypothesize that this is the result of mislocalization of Fis1 interactors
required at the mitochondrion for normal morphology. To identify these potential
interactors, we employed a yeast two-hybrid (Y2H) interaction screen. Using full-length
Fis1 as bait, 46 million clones were screened for Y2H interaction and 247 were selected
for identification. The putative interactors were then given a confidence score based on
the likelihood of interaction with Fis1 (19, 20). This resulted in 24 potential interactors
with a global predicted biological score (PrBS) from A (highest confidence) to D (lowest
confidence) (19, 20) (Table 1). To narrow down the list, we immunoprecipitated the
exogenous HA-tagged Fis1 using HA-conjugated beads and analyzed the precipitated
complex by mass spectroscopy. For a control, we used the parental RHΔhpt strain,
which does not express the hemagglutinin tag. Through this analysis, we identified 11
putative interactors that had at least five peptides in the Fis1 sample and no peptides
in the control sample (see Table S1 in supplemental material). Among these interactors,
only one was also identified in the Y2H interaction screen, TGGT1_265180.
To determine the localization of TGGT1_265180, we introduced a C-terminal myc
epitope tag to the endogenous gene. IFA assays of the resulting strain show that, like
Fis1, TGGT1_265180 is localized to the mitochondrion of intracellular parasites (Fig. 5A).
This association with the mitochondrion persists during parasite division (Fig. 5B). To
determine whether the protein is associated with the outside or inside of the mito-
chondrion, we performed IFA after permeabilization with various concentrations of
digitonin using detection of F1B ATPase to monitor mitochondrial permeabilization
(Fig. 5C). When using 0.01% digitonin, we can detect both F1B ATPase and
TABLE 1 Proteins identified as Fis1 interactors through a yeast two-hybrid screena
Gene ID Product description PrBSb
TGGT1_215520 Hypothetical protein A
TGGT1_218560 Acetyl-CoA carboxylase ACC2 B
TGGT1_222800 Glycogen synthase, putative B
TGGT1_265180 Hypothetical protein B
TGGT1_224270 Hypothetical protein C
TGGT1_293840 Hypothetical protein C
TGGT1_201390 Hypothetical protein D
TGGT1_226050 Hypothetical protein D
TGGT1_237015 GRA43 D
TGGT1_246720 Hypothetical protein D
TGGT1_247700 AP2 domain transcription factor AP2XII-4 D
TGGT1_284620 Hypothetical protein D
TGGT1_286470 AGC kinase D
TGGT1_287980 FHA domain-containing protein D
TGGT1_297770 Hypothetical protein D
TGGT1_299670 Hypothetical protein D
TGGT1_304990 Guanylate-binding protein D
TGGT1_321370 Hypothetical protein D
TGGT1_321450 Myb family DNA-binding
domain-containing protein
D
aProteins that were also identified in the mitochondrial proteome (35) are shown in boldface type. ID,
identifier; acetyl-CoA, acetyl coenzyme A.
bPredicted biological scores (PrBS) are confidence scores, with A indicating the highest confidence of
interaction and D the lowest confidence of interaction (19, 20).
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TGGT1_265180 (Fig. 5C). In contrast, using 0.005% digitonin allows for detection of
TGGT1_265180 but not F1B ATPase. This result mimics what is seen with Fis1 (Fig. S2),
and thus, like Fis1, TGGT1_265180 likely associates with the OMM and faces the
cytoplasm of the parasite (Fig. 5C). Association with the OMM was confirmed by
treatment with monensin. After treating TGGT1_265180(myc) expressing parasites with
monensin, we observed a pattern similar to that of Fis1 in which fragments containing
the IMM marker F1B ATPase are surrounded and connected by TGGT1_265180 (Fig. 5D).
PhaseA.
B.
C.
D.
F1BATPase
265180(myc)
265180(myc)
265180(myc)
Overlay
Phase F1BATPase 265180(myc) Overlay
Phase AcTubulin Overlay
DNA
0.005%
digitonin
0.01%
digitonin
F1BATPase
FIG 5 Fis1 interactor TGGT1_265180 localizes to the outer mitochondrial membrane. To investigate the localiza-
tion of TGGT1_265180, we introduced sequences encoding an N-terminal myc tag to the endogenous locus. (A)
Intracellular parasites of the TGGT1_265180(myc)-expressing strain were stained for mitochondrial F1B ATPase (red)
and myc (green). (B) Intracellular parasites of the same strain were stained for myc (green) and acetylated tubulin
(red), which clearly demarcates daughter parasites during division. (C) Intracellular parasites of the
TGGT1_265180(myc)-expressing strain were fixed and permeabilized with either 0.005% or 0.01% digitonin before
staining for the IMM protein F1B ATPase (red) and myc (green). TGGT1_265180 can be detected when F1B ATPase
remains inaccessible to the antibodies, suggesting that it is associated with the OMM. (D) TGGT1_265180(myc)
parasites were treated with 5 mM monensin for 5 h. Mitochondrial morphology was monitored by IFA for
TGGT1_265180(myc) (green) and F1B ATPase (red). Bars, 2 m.
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Thus, TGGT1_265180 localizes to the OMM, as expected for a bona fide interactor of
Fis1.
Localization of TGGT1_265180 is partially dependent on proper Fis1 localiza-
tion. Despite its association with the OMM, TGGT1_265180 has no predicted trans-
membrane domains or posttranslational modifications that would suggest membrane
interaction. Therefore, we hypothesize that the localization of TGGT1_265180 occurs via
protein-protein interaction. To test this idea, we transfected parasites with an ectopic
copy of either full-length or truncated TGGT1_265180 carrying a C-terminal HA epitope
tag and under the control of the TGGT1_265180 promoter (Fig. 6A). The truncated form
lacks the C-terminal 92 amino acids, which represent the region of the protein that was
identified through the Y2H screen as interacting with Fis1, referred to as the selected
interaction domain (SID). As expected, the full-length ectopic copy localized to the
mitochondrion (Fig. 6A). However, deletion of the SID resulted in the mislocalization of
the protein to the cytoplasm (Fig. 6A). These data indicate that the C-terminal SID is
necessary for proper mitochondrial localization.
To investigate whether localization of TGGT1_265180 to the mitochondrion is
through an interaction with Fis1, we added a myc epitope tag to the endogenous
TGGT1_265180 in the strain in which Fis1 lacks its TM (RHΔku80:Fis1ΔTM) and is
mislocalized to the cytoplasm. In this strain, TGGT1_265180 does not colocalize with
the mislocalized Fis1 but appears to accumulate toward the basal end of the parasites
in a pattern that does not resemble normal mitochondrial localization (Fig. 6B). To
further analyze the localization of TGGT1_265180 in the RHΔku80:Fis1ΔTM parasite line,
we costained for F1B ATPase (Fig. 6C). While we observed some overlap between the
TGGT1_265180 and F1B ATPase signals, TGGT1_265180 was also detected away from
the mitochondrion (Fig. 6C). Interestingly, we observed that the TGGT1_265180(myc)
signal, as detected through IFA, appeared to be much weaker in the Fis1ΔTM strain
than in the parental strain (Fig. 6C). To quantitate this observation, we performed
Western blotting from both strains probing for TGGT1_265180(myc) (Fig. 6D). This
analysis corroborated that indeed the levels of endogenous TGGT1_265180 are signif-
icantly reduced when Fis1 is mislocalized away from the mitochondrion (Fig. 6D). We
quantitated the levels of TGGT1_265180 in both strains by performing densitometry of
three independent Western blots using the surface antigen SAG1 as a loading control
and determined that the level of TGGT1_265180 in the RHΔku80:Fis1ΔTM is
23.2%  8.7% of that in the parental strain. In conjunction, these results indicate that
TGGT1_265180 associates with the mitochondrion via its C terminus and that its
localization and stability are at least in part dependent on Fis1.
265180 knockout affects parasite fitness in tissue culture. Based on a genome-
wide CRISPR screen, TGGT1_265180 was assigned a relative fitness phenotype score of
1.65, which indicates that, while its absence would negatively affect parasite fitness,
it is likely not essential, making its genetic disruption possible (21). Accordingly, we
employed double homologous recombination to replace the coding sequence of
TGGT1_265180 with a drug selection marker (Fig. 7A). Proper integration of the
knockout construct in stably transfected clones was confirmed by PCR (Fig. 7B). To test
the effect of the knockout on parasite propagation, we used a standard growth assay
in which the same number of parasites (parental or mutant parasites) were allowed to
infect human fibroblasts and form plaques over a 5-day period. We observed a
significant propagation defect in the 265180 parasites, exhibited by both fewer
and smaller plaques in comparison to the parental strain. To quantitate this defect,
we counted the number of plaques formed by the parental and knockout strains in
three separate experiments, each with experimental triplicates (Fig. 7C). The aver-
age number of plaques by the 265180 was 30.2%  9.0% of that detected for the
parental strain.
To confirm that the phenotype observed was due to the disruption of the target
gene and not a secondary effect, we complemented the 265180 strain with an
exogenous copy of the TGGT1_265180 including a C-terminal HA epitope tag and
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driven by its own promoter. As the knockout strain lacks Ku80 and does not effectively
allow for random integration, the exogenous copy was directed to the remnants of the
Ku80 locus using CRISPR/Cas9. In addition to complementing with the wild-type
TGGT1_265180, we transfected the knockout strain with the truncated version
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FIG 6 Association of TGGT1_265180 with the mitochondrion depends on Fis1. To investigate how TGGT1_265180
associates with the mitochondrion, we tested the roles of its C terminus and Fis1 on its localization. (A) Parasites
were transfected with an exogenous copy of C-terminally HA-tagged wild-type TGGT1_265180 or with N-terminally
HA-tagged TGGT1_265180 lacking the selected interaction domain (SID). The SID is the region of TGGT1_265180
that was identified as interacting with Fis1. Intracellular parasites expressing TGGT1_265180-HA (left) or
TGGT1_265180ΔSID-HA (right) were stained for HA. (B) Intracellular FisΔTM-HA parasites expressing an endoge-
nous copy of C-terminally myc-tagged TGGT1_265180 were probed for HA to detect Fis1 (red) and for myc to
detect TGGT1_265180 (green). (C) Wild-type or FisΔTM-HA parasites endogenously expressing TGGT1_265180-Myc
were stained for F1B ATPase (red) and myc (green) to monitor localization of TGGT1_265180. Bars, 2 m. (D)
Representative Western blot of extract from wild-type (WT) and Fis1ΔTM parasites expressing TGGT1_265180-myc
probed for myc (top blot) and SAG1 (bottom blot) as a loading control.
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FIG 7 Knockout of TGGT1_265180 affects parasite propagation. To investigate the role of TGGT1_265180 in
parasite fitness, we established knockout and complemented strains. (A) Schematic of strategy implemented to
disrupt the TGGT1_265180 by replacing the coding sequences by the selectable marker HXPRT. On top is the vector
used to drive the gene replacement, which includes HXPRT flanked by areas of homology to the TGGT1_265180
locus (dark gray boxes) and a downstream copy of GFP that is not integrated upon the desired double homologous
recombination and can be used as a negative selectable marker. Endogenous TGGT1_265180 is depicted in the
middle with coding sequences represented by a black box. The bottom drawing shows the expected result from
gene replacement in the knockout strain. P1, P2, and P3 indicate the PCR amplicons that were used to confirm
integration. P1 would be detected only from parental parasites, P2 only from knockout parasites, and P3 from both.
(B) PCR products from reactions to detect P1, P2, and P3 in the parental strain and the established Δ265180 clone.
(C) Average number of plaques per well for either parental or knockout strains after 4-day incubation period. Plaque
assays were done in biological and technical triplicates, with error bars representing SD. Statistical analysis was
performed by the t test (****, P  0.0001). (D) Diagrams depict the two constructs used for complementation:
TGGT1_265180-HA and TGGT1_265180ΔSID-HA. SID is the selected interaction domain identified through the
two-hybrid screen. (E) Representative Western blot of a strain in which the endogenous TGGT1_265180 includes
a HA epitope tag (parental [Par]), and the knockout strain complemented with wild-type TGGT1_265180-HA (KO
comp WT) or with TGGT1_265180ΔSID-HA (KO comp ΔSID) probed for HA (top blot) and for SAG1 (bottom blot)
as a loading control. (F) Average number of plaques per well for each strain after 4-day incubation period. Plaque
assays were done in biological and technical triplicates, with error bars representing SD. Statistical analysis was
performed by one-way ANOVA (****, P  0.0001; **, P  0.0019; n.s., not significant).
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TGGT1_265180ΔSID, which does not localize to the mitochondrion (Fig. 7D). Western
blots showed that both complemented strains expressed proteins of the expected size
(Fig. 7E). Interestingly, while the wild-type complement expression level is similar to
that of the endogenous levels, the truncated copy appears to be expressed at a much
higher level (Fig. 7E). Plaque assays of both the 265180 265180(HA) and
265180 265180ΔSID(HA) strains were performed in parallel with the knockout strain
(Fig. 7F). The average number of plaques by the 265180 265180(HA) was
64.5%  15.8, which is significantly higher than both the knockout and truncated
complemented strains (Fig. 7F). 265180  265180ΔSID(HA) had a lower average
number of plaques (21.6%  8.0) than that of the knockout (38.8%  15.3), but this
difference was not statistically significant. These results indicate that proper local-
ization of TGGT1_265180 is necessary to rescue the growth phenotype seen in
tissue culture.
265180 disrupts the normal morphology of the mitochondrion. As TGGT1_
265180 is associated with the mitochondrion, we assessed mitochondrial morphology
in the knockout parasites. In intracellular parasites, the mitochondrion maintains what
is referred to as a lasso shape that abuts the periphery of the parasite (11) (Fig. 2 and
8A). However, based on staining with antibodies against F1B ATPase, the mitochon-
drion of 265180 parasites exhibit an altered mitochondrial morphology, with the bulk
of the mitochondrial material concentrated at one end of the parasite (Fig. 8A). In
contrast, disruption of TGGT1_265180 did not affect the morphology of the apicoplast,
rhoptries, or endoplasmic reticulum (Fig. S3). Introduction of the wild-type TGGT1_
265180 to the knockout strain complements the mitochondrial phenotype (Fig. 8B). In
contrast, the truncated TGGT1_265180SID, which is not localized to the mitochon-
drion, does not rescue the collapsed mitochondrion phenotype (Fig. 8C). The pheno-
type of the knockout and complemented strains was quantitated by determining the
percentage of parasites with normal and abnormal mitochondrion morphology. Nor-
mally, the Toxoplasmamitochondrion retracts from the periphery of the parasite during
egress and changes its morphology to what has been described as sperm-like and
collapsed (11). Interestingly, we observed all three morphologies normally associated
with extracellular parasites (lasso, sperm-like, and collapsed) in intracellular parasites of
the 265180 strain (Fig. 9A). With the parental strain, the proportion of mitochondrial
morphologies in intracellular parasites is 84.7%  2.1% lasso, 15.3%  2.1% sperm-like,
and 0% collapsed. In contrast, for intracellular parasites of the 265180 strain, the
mitochondrial distribution is 6.0%  2.6% lasso, 50.0%%  2% sperm-like, and
44.0%  4.4% collapsed (Fig. 9B). As was the case for the plaquing phenotype,
introduction of a wild-type copy of TGGT1_265180 partly rescues the morphological
phenotype with 48.5%  4.4% of parasites exhibiting lasso-shaped mitochondrion,
49.2%  3.9% sperm-like, and only 2.3%  0.6% collapsed. Additionally, the truncated
copy had a morphological distribution similar to that of the knockout strain (2.7%
 2.3% lasso, 56.0%  10.1% sperm-like, and 41.4%  12.4% collapsed) and was
significantly different from the distributions of the parental and complemented strains,
which is consistent with defects seen in plaquing (Fig. 9B). Thus, TGGT1_265180 plays
a crucial role in maintaining proper morphology of the mitochondrion. Consequently,
we have dubbed this new protein lasso maintenance factor 1 (LMF1).
Disruption of LMF1 results in defects in mitochondrial segregation between
daughter parasites. During our analysis of mitochondrial morphology in the LMF1
mutant strain, we noted various aberrant phenotypes that likely relate to parasite
and mitochondrial division. Toxoplasma divides through a process called
endodyogeny, where two daughter parasites form within a mother parasite (22).
This results in a doubling in the number of parasites in a vacuole after each round
of replication. We noted that vacuoles of the LMF1 strain often had abnormal
numbers of parasites (i.e., not 2, 4, 8, etc.). We found that approximately
25.3%  5.1% of vacuoles in 265180 parasites had odd numbers compared to
5.8%  2.9% in wild-type parasites and 13.7%  3.1% in the complemented strain
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(Fig. 10A). Interestingly, we also noticed numerous vacuoles in which some para-
sites lacked a mitochondrion based on the absence of F1B ATPase staining (Fig. 10B,
white arrows). When quantified, 16.2%  4.0% of vacuoles contained at least one
parasite that did not have mitochondrial material compared to 0.3%  0.6% of
RHΔku80 parasites that were amitochondriate (Fig. 10B). As with the other pheno-
types, exogenous expression of wild-type LMF1 complemented the phenotype with
6.0%  1.7% of vacuoles containing amitochondriate parasites. In addition to
amitochondriate parasites, disruption of LMF1 also results in an accumulation of
mitochondrial material outside parasites (Fig. 10C, white arrows). We determined that
30.9%  4.0% of vacuoles had extraparasitic mitochondrial material, which is three times
greater than that of the parental parasite line (10.6%  3.2%). Interestingly, this particular
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FIG 8 Mitochondrial morphology is disrupted by the absence of TGGT1_265180. To determine the effect of
TGGT1_265180 ablation on the mitochondrion, knockout and complemented parasites were analyzed by IFA. (A)
Intracellular parasites of the parental or Δ265180 strain were stained for F1B ATPase (green) to monitor mitochon-
drion and for acetylated tubulin (acTub) to detect the parasite cytoskeleton (red). (B and C) IFA of knockout
parasites (Δ265180) transformed with either the wild-type [265180(HA)] or truncated [265180ΔSID(HA)]
TGGT1_265180 with antibodies against F1B ATPase (red) and HA (green). Bars, 2 m.
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phenotype was not complemented, as 28.3%  2.1% of 265180 265180(HA) vacuoles
contained extraparasitic material (Fig. 10C).
We hypothesize that these phenotypes (abnormal number of parasites, amito-
chondriate parasites, and extraparasitic mitochondria) are the result of aberrant
segregation of the mitochondrion into the daughter cells during endodyogeny.
Accordingly, we costained parental and knockout parasites for acetylated tubulin to
detect daughter cells and for F1B ATPase to monitor the mitochondrion (Fig. 11).
During the early (E) stages of division, wild-type parasite mitochondria surround the
forming daughter cells (Fig. 11A, top panels). As endodyogeny progresses to an
intermediate (I) stage, the mitochondrion remains excluded from the daughters
(Fig. 11A, middle panels). When the daughters have almost fully formed (late [L]
stages), branches of mother mitochondria incorporate into the daughter parasites
before emerging from the mother (Fig. 11A, bottom panels). When LMF1 is dis-
rupted, the mitochondrion does not have the typical lasso shape and appears to
associate with one of the two daughters instead of surrounding both (Fig. 11B, top
panels [E]). As the daughters continue to form in the LMF1-deficient parasites, the
mitochondrial material remains associated with one daughter or is completely
excluded from the budding daughters (Fig. 11B, I panels). During the final stages of
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FIG 9 Intracellular parasites lacking TGGT1_265180 do not maintain their mitochondrion in the lasso
conformation. To determine the penetrance of the mitochondrial phenotype observed in the Δ265180
strain, the different morphological patterns observed were quantitated. (A) Intracellular parasites of the
Δ265180 strain stained for F1B ATPase (green) and acetylated tubulin (red) exhibiting three distinct
mitochondrial morphologies: lasso, collapsed, and sperm-like. Bar, 2 m. (B) Percentage of parasites with
each of the three different morphologies for the parental (par), knockout (Δ265180), and complemented
[Δ265180 265180(HA) and Δ265180 265180ΔSID(HA)] strains. Data are average of biological tripli-
cates, at least 50 vacuoles per sample were inspected. Error bars are SD. Statistics shown are ANOVA of
percentage of parasites with lasso shape for each strain. ****, P  0.001; **, P  0.004; ##, P  0.003; %%,
P  0.002; n.s., not significant.
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endodyogeny, some daughters seem to have received mitochondrial material,
whereas others have not. This correlates to an accumulation of mitochondrial
material outside the parasites (Fig. 11B, bottom three panels [L panels and unla-
beled panels]). Therefore, disruption of LMF1 leads to defects in mitochondrial
segregation during endodyogeny, which agrees with the aberrant phenotypes
observed with mitochondrial shape and localization (Fig. 9 and 10).
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FIG 10 Parasites lacking TGGT1_265180 exhibit various division-related phenotypes. IFA of knockout
parasites stained for F1B ATPase (green) and acetylated tubulin (red) reveal various aberrant phenotypes.
(A) The images on the left show a Δ265180 vacuole containing five parasites rather than either four or
eight as expected. The graph shows the percentage of vacuoles with abnormal number of parasites for
the three strains. (B) Images show vacuole with amitochondriate parasites (arrows) based on the absence
of F1B ATPase signal. The graph shows the percentage of vacuoles with at least one amitochondriate
parasite for each strain. (C) Images show a vacuole that contains parasites with F1B ATPase signal outside
the parasite and within the parasitophorous vacuole (arrows). Bars, 2 m. The graph shows the percent-
age of vacuoles with this phenotype. For all graphs, n 3  SD with at least 50 vacuoles per sample
inspected. Statistical analysis was done with one-way ANOVA and a Tukey posthoc test. ***, P  0.0006;
**, P  002; *, P  0.02; ##, P  0.006; %%, P  0.001; n.s., not significant.
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DISCUSSION
The single mitochondrion of the pathogen Toxoplasma gondii is highly dynamic,
with its location and structure changing during various stages of the parasite’s lytic
cycle. As the last organelle to move from a live mother parasite into two nascent
daughter cells, the morphology and position of the mitochondrion are tightly regulated
during parasite division. Similarly, as the parasite moves from inside to outside host
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FIG 11 TGGT1_265180 disruption results in mitochondrial segregation defects. To examine mitochon-
drial dynamics during parasite division, IFAs of parasites during early (E), intermediate (I), and late (L)
stages of endodyogeny were conducted. (A) IFAs of intracellular wild-type parasites. (B) IFAs of intra-
cellular Δ265180 (also known as LMF1) knockout parasites. In both panels A and B, the stage of division
was determined by DAPI staining (blue) and acetylated tubulin (red), which demarcate budding
daughters. Mitochondrial morphology was observed by staining with F1B ATPase, shown here in green.
Bars, 2 m.
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cells, the mitochondrion morphology dramatically changes. While inside the host cell,
Toxoplasma’s mitochondrion forms a lasso with multiple points of contact with the
parasite pellicle and then quickly retracts from the parasite periphery to a collapsed
bundle at the apical end as the parasites move to the extracellular space. In this study,
we show that the mitochondrial morphology also changes under treatment with the
antiparasitic drugs atovaquone and monensin. With drug treatment, the mitochondri-
on’s outer membrane becomes constricted, causing the inner mitochondrial material to
appear punctate. Importantly, this phenomenon is completely reversible, and upon
removal of monensin, the mitochondrion returns to its typical shape. We also show that
mitochondrial constriction upon monensin treatment is partly dependent on the
presence of the fission protein Fis1 at the mitochondrion. Thus, we have discovered a
mechanism by which the parasite reversibly restructures its mitochondrion.
The morphological changes experienced by the mitochondrion under monensin
treatment are likely a response to stress and might represent a mechanism by which
the parasite protects the mitochondrion from irreversible damage. Mitochondria from
numerous organisms alter their morphology to respond to specific stressors, such as UV
radiation and nutrient starvation (23–26). In conditions that damage mitochondrial
DNA, such as cycloheximide and UV radiation, mitochondria hyperfuse (23). This
phenomenon most likely occurs to complement damaged mitochondrial DNA and
promote DNA mixing. Conditions that affect mitochondrial respiration, such as oligo-
mycin and uncoupling agents, cause mitochondrial fragmentation (25, 26). Similarly,
the mitochondria in Saccharomyces cerevisiae cultured in aerobic, respiratory conditions
are more punctate, whereas when S. cerevisiae is cultured under anaerobic conditions,
the mitochondria are branched and elongated (24). These data suggest that mitochon-
drial morphology is dependent upon environmental conditions and stressors. There-
fore, the phenotype we see under monensin treatment is likely a protective mechanism
for the mitochondrion against the effects of the ionophore.
As the effect of monensin is a reversible constriction along the outer mitochondrial
membrane, we hypothesize that this phenomenon would require the mitochondrial
fission machinery. The yeast mitochondrial fission machinery is the most well charac-
terized, and it is comprised of the membrane-anchored protein Fis1p, which actively
recruits other proteins to the mitochondria during fission like Mdv1 (mitochondrial
division protein 1), which acts as an adaptor protein. Fis1p is then able to recruit a
GTPase, dynamin (Dmn1), which is able to drive the final scission of the mitochondrion
(5). No homologs for Mdv1 have been found in Toxoplasma gondii, but there are one
Fis1 homolog (TGGT1_263323) and three dynamin-related proteins: DrpA, DrpB, and
DrpC. Of these Drp proteins, DrpC, which lacks many of the features required for Drp
function, has been associated with mitochondrial division (9). Nonetheless, we and
other groups have shown that instead DrpC appears to be involved in vesicle trafficking
and endocytosis (9, 10). As Fis1 is the strongest homolog of any putative fission protein
in Toxoplasma, we investigated the role of Fis1 in monensin-driven mitochondrial
rearrangement. We found that Fis1 localization to the mitochondrion is important for
monensin-induced remodeling and that the absence of Fis1 results in decreased
sensitivity to the ionophore. Thus, it is plausible that Fis1 is recruiting proteins to the
mitochondrion outer membrane during monensin treatment to induce a transient
constriction, similar to the transient interaction Fis1 has with Drp1 (27, 28). As DrpC and
Fis1 do not seem to interact and DrpC localization does not change upon monensin
treatment, it is unlikely that DrpC is involved in this process. Interactome analysis of Fis1
identified some proteins with domains of interest that are also found in Fis1 interactors
of other systems. For example, TGGT1_224270 contains WD40-like domains, which is
common to the Fis1 adaptor proteins (27, 29). TGGT1_304990 is a guanylate-binding
protein that may be able to take the role of a dynamin-related protein in this system.
While Fis1 is essential in yeast, mammalian cells appear to have several proteins able
to recruit the fission machinery, which makes Fis1 dispensable in those organisms.
Knockout of Toxoplasma Fis1 does not disrupt mitochondrial morphology (30) or affect
parasite fitness (21, 30). These results are corroborated by our experiments in which the
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endogenous Fis1 gene was disrupted through CRISPR/Cas9 (see Fig. S1 in the supple-
mental material). Interestingly, we do observe a significant defect in the morphology of
the mitochondrion when the endogenous Fis1 is mislocalized to the cytoplasm. In both
mammalian cells and in yeast, either mislocalization or overexpression of Fis1 results in
disruption of mitochondrial morphology (27, 31). In Toxoplasma, mislocalization of Fis1
resulted in aberrant mitochondrial morphology in which they maintain their lasso
shape, but it is stretched out and appears to have strenuous branches and material. The
phenotype observed with mislocalized Fis1 could be the consequence of Fis1 interact-
ing with proteins that it would normally not come into contact with or of Fis1 pulling
proteins away from the mitochondrial membrane where they are required. With this in
mind, we performed a yeast two-hybrid screen to identify putative interactors. Inter-
estingly, among the 24 proteins identified, seven (TGGT1_215520, TGGT1_218560,
TGGT1_265180, TGGT1_246720, TGGT1_304990, TGGT1_321370, and TGGT1_321450)
likely localize to the mitochondrion, based on a proteomic analysis of the Toxoplasma
mitochondrion, which uses both *BirA (32) and ascorbate peroxidase (APEX) (33, 34) to
identify novel mitochondrial proteins (35). Nonetheless, this proteome may not contain
all the potential interactors that localize to the mitochondrion because the proteome
was generated using a mitochondrial matrix protein, HSP70, thus excluding proteins
that are localized to the outer mitochondrial membrane. In silico analysis of the putative
Fis1 interactors using MitoProt, SignalP, and PSort (36–38) shows that an additional
five proteins (TGGT1_226050, TGGT1_237015, TGGT1_247700, TGGT1_299670, and
TGGT1_286470) may also localize to the mitochondrion based on the presence of
mitochondrial signal. Another protein of interest is TGGT1_287980 has a forkhead-
associated (FHA) domain, which is involved in a number of regulatory and signaling
processes (39). Further characterization of these proteins is needed to determine what
role they may play in mitochondrial remodeling and dynamics.
In this study, we focused on one of the putative Fis1 interactors, TGGT1_265180,
which we have dubbed LMF1. This protein was the only protein identified through both
the Y2H and a small-scale coimmunoprecipitation assay. LMF1 localizes to the OMM
despite the absence of any domain or modification that would predict mitochondrial or
membrane localization, suggesting that its association with the mitochondrion is likely
through protein-protein interactions. When Fis1 is mislocalized to the cytoplasm, LMF1
expression is significantly reduced, and while some LMF1 is still deposited on the
mitochondrion, other remnants do not appear to be associated with the organelle.
LMF1 may not colocalize with Fis1 in these parasites because either protein may be
interacting with other proteins or membranes. In the case of LMF1, there are potentially
redundant interactors on the mitochondrial surface or interactors localized to other
parts of the parasite, like the IMC, that are important for maintaining the mitochondrial
lasso shape. Additionally, the expression level of LMF1 is decreased significantly when
Fis1 is mislocalized, which may be due to either a decrease in the transcript level of
LMF1 or due to the protein being degraded in the absence of potentially stabilizing Fis1
interactions.
Genetic disruption of LMF1 reveals its unexpected role in maintenance of mitochon-
drial morphology in intracellular parasites. LMF1 knockout results in loss of the typical
lasso arrangement with the majority of parasites having either sperm-like or collapsed
mitochondria. Thus, it appears that in the absence of LMF1, the mitochondrion of
intracellular parasites adopts morphology normally only seen in extracellular ones.
These mitochondrial morphologies, sperm-like and collapsed, are proposed to be due
to a retraction of the mitochondrion from the IMC, as the parasite transitions to the
extracellular environment. Therefore, it is possible that elimination of LMF1 has also
eliminated these contact sites, causing a significant decrease in parasites with lasso
morphology intracellularly. Membrane contact sites (MCSs) play important roles in
signaling, lipid and ion exchange between organelles, and proper organelle positioning
(40, 41). Whether any of these processes are affected in the LMF1 mutant strain is yet
to be investigated. Nonetheless, the fact that parasites lacking LMF1 exhibit a propa-
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gation defect suggest that the proper morphology of the mitochondrion is important
for parasite fitness.
We noted that complementation of the knockout strain with the wild-type LMF1
was incomplete. While the exogenous copy was under the control of the LMF1
promoter, it is possible that the expression level from the ectopic site is not at the right
level for complete complementation. Another possibility is that, in order to adapt to the
lack of LMF1, the expression of other factors required for mitochondrial morphology
was affected. It is also plausible that that the addition of an epitope tag in the
exogenous protein affects function or protein-protein interactions. Nonetheless, we
have not observed any mitochondrial defect when epitope tags are added in the
endogenous LMF1. Future experiments using conditional knockout of LMF1 will pro-
vide a better controlled system to study this mechanism.
Altering mitochondrial morphology is important in many systems to accommodate
energetic needs and change positioning of organelles to perform specific functions. For
example, Trypanosoma brucei is another parasite that contains a single mitochondrion
that alters its shape in different life stages (42). During the procyclic phase in the tsetse
fly midgut, the mitochondrion elongates to form an elaborate network of mitochon-
drial branches. In the bloodstream form, the branches collapse to form one tubule that
lacks the respiratory capability of the procyclic stage. This mitochondrial morphology
change is dependent on a protein called T. brucei LOK1 (TbLOK1), which is naturally
downregulated in the bloodstream form (42). Based on this knowledge, it is possible
that the retraction from the IMC toward the apical end of the parasite during extra-
cellular stress is to (i) position the mitochondrion to the area of greatest energetic need
and/or (ii) accommodate to the available nutrients. We propose that LMF1 interacts
with Fis1 on the OMM and another or multiple proteins in the parasite pellicle to
establish membrane contact sites to maintain the typical lasso shape. Upon egress,
LMF1 or its interactors is either posttranslationally modified or downregulated so as to
eliminate these contact sites and position the mitochondrion toward the apical end.
Once the parasite has reentered a host cell, the mitochondrion can then reattach to the
pellicle and can extend to the parasite periphery. LMF1 knockout parasites cannot
properly form this lasso and therefore have given us an incredible tool to study the
functional relevance of the mitochondrial morphodynamics and to identify the key
players in this process.
MATERIALS AND METHODS
Host cell and parasite maintenance. All parasite strains were maintained via continued passage
through human foreskin fibroblasts (HFFs) (purchased from ATCC) in normal growth medium, which
consisted of Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum
(FBS), 2 mM L-glutamine, and 100 U penicillin/100 g streptomycin per ml. All cultures were grown in a
humidified incubator at 37°C and 5% CO2. Parasites used were of the strain RH lacking hypoxanthine-
xanthine-guanine phosphoribosyltransferase (HPT) (RHΔhpt) (43) and RH lacking HPT and Ku80
(RHΔku80Δhpt, referred to as Δku80 thereafter) (44, 45). For experiments involving drug treatment, the
medium was supplemented with 1% FBS rather than 10% FBS. For pyrimethamine treatment, we used
dialyzed serum. All drugs were purchased from Sigma. Stocks of monensin, pyrimethamine, and
myxothiazol were prepared in ethanol, while atovaquone was prepared in dimethyl sulfoxide (DMSO).
Generation of transgenic parasites. Parasites were engineered to express ectopic copies of
full-length Fis1 (TGGT1_263323) or a truncated version lacking the putative transmembrane (TM)
domain. For this purpose, PCR was utilized to amplify the Fis1 cDNA and append a hemagglutinin (HA)
tag at the N terminus. The amplicon was flanked by NsiI and PacI restriction enzyme sites. Table S2 in the
supplemental material lists all the primers used throughout this study. Purified PCR fragments were
inserted into the pHEX2 plasmid (46) using the In-Fusion HD Cloning Plus kit (Clontech). Expression of
the transgenes was controlled by the SAG1 promoter, and selection was provided by the presence of the
HPT selectable marker (43). KpnI-linearized plasmids (35 g) were electroporated into parental RHΔhpt
parasites (47), and selection of parasites that successfully integrated the plasmid was achieved by
growing parasites in medium containing 50 g mycophenolic acid per ml and 50 g xanthine per
ml. Three rounds of drug selection were followed by limited dilution cloning to establish HA
tag-positive parasite lines with and without the transmembrane domain termed RHΔhptHAFis1
and RHΔhptFis1ΔTM, respectively.
To generate a parasite line expressing an endogenous Fis1 lacking the TM (RHΔku80:Fis1ΔTM), a
fragment of the Fis1 gene comprising the region just upstream of the TM and flanked by PacI and AvrII
was PCR amplified from Toxoplasma genomic DNA and inserted into the pLIC-HA(3x)-DHFR plasmid (44)
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by In-Fusion cloning. EcoRV-linearized plasmid (35 g) was transfected into Δku80 parasites (44). The
resulting transfectants were selected for dihydrofolate reductase (DHFR) by growth in medium with 1 M
pyrimethamine and cloned by limited dilution.
For C-terminal endogenous epitope tagging of TGGT1_265180, a PacI-flanked fragment of
TGGT1_265180 just upstream of its stop codon was PCR amplified and inserted into pLIC-myc(3x)-DHFR
by In-Fusion cloning. XcmI-linearized plasmid (60 g) was transfected into Δku80 parasites, and trans-
fectants were selected for DHFR as described above.
Double homologous replacement of the TGGT1_265180 coding sequence was used to establish a
knockout strain. For this purpose, we generated a knockout construct using the previously described
pminiGFP vector (48). Using In-Fusion cloning, we introduced a 1,400-bp PCR amplicon encompassing
the region upstream of the TGGT1_265180 start codon into the HindIII restriction site of pminiGFP and
a 1,156-bp amplicon of the region downstream of the stop codon into the NotI restriction site. In this
manner, the resulting vector (p265180_KO [KO stands for knockout]) has a drug selection cassette, HPT,
flanked by regions of homology to the sequences upstream and downstream of TGGT1_265180. Ten
micrograms of DraIII-linearized p265180_KO was transfected into Δku80 parasites using Nucleofector
(Lonza), and parasites were then selected for the expression of HPT as described above. Disruption of
TGGT1_265180 was confirmed by PCR using three primer sets (Table S2). The first primer set (P1)
amplifies a 637-bp region present in wild-type parasites and absent in the knockout strain (Fig. 7A). The
second primer set (P2) was designed to amplify a 1,933-bp fragment present only if the double
homologous recombination of the knockout construct occurred at the TGGT1_265180 locus (Fig. 7A). The
final primer set (P3) amplifies a fragment in both the wild-type and knockout strains (Fig. 7A).
For exogenous expression of TGGT1_265180, a 3,700-bp fragment beginning approximately 2 kb
upstream of the TGGT1_265180 start codon and ending at its stop codon was PCR amplified from
genomic DNA. This PCR amplicon was inserted into the PacI site of pLIC-HA(3x)-DHFR by In-Fusion
cloning. The same method was used to create a plasmid lacking the predicted selected interaction
domain (SID), thus truncating the gene. These plasmids were used as the templates to amplify an 8-kb
fragment that included the TGGT1_265180 gene under the control of its own promoter, a triple
hemagglutinin tag, and the DHFR drug selection cassette. Primers used included overhangs homologous
to the remnants of the Δku80 site on each side of a double-stranded cut created by CRISPR/Cas9. The
8-kb PCR fragment was gel extracted using the NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel)
and eluted in P3 buffer (Lonza) for nucleofection. The pSAG1-Cas9-U6-sgUPRT plasmid, generously
provided by the Sibley lab (18), was mutated to contain a guide RNA targeted to the Ku80 site.
TGGT1_265180 knockout and parental parasites were transfected with 1 g of either the full-length
(265180-HA) or truncated (265180ΔSID-HA) PCR amplicons and 2 g of pSAG1-Cas9-sgKu80 using the
Nucleofector (Lonza). Parasites were selected for the presence of DHFR as described above. Immuno-
fluorescence and Western blotting (see below) were used to confirm expression and localization of the
exogenous copies of TGGT1_265180.
Immunofluorescence microscopy analysis. For immunofluorescence assay (IFA), infected HFFs
were fixed with 3.5% formaldehyde, quenched with 100 mM glycine, and blocked and permeabilized in
phosphate-buffered saline (PBS) containing 3% bovine serum albumin (BSA) and 0.2% Triton X-100
(TX-100) (PBS/3% BSA/0.2% TX100). Samples were then incubated with primary antibodies in PBS/3%
BSA/0.2% TX100 for 1 h, washed five times with PBS, and incubated with Alexa Fluor-conjugated
secondary antibodies in PBS/3% BSA for 1 h. The coverslips were washed with PBS and mounted on glass
slides with 3 l 4=,6=-diamidino-2-phenylindole (DAPI) containing Vectashield. For three-dimensional
structured illumination microscopy (3D-SIM), coverslips were stained with a liquid DAPI solution in PBS,
washed, and inverted on a glass slide with Vectashield mounting medium without DAPI. Image
acquisition and processing were performed on either a Nikon Eclipse 80i microscope with NIS-Elements AR
3.0 software or a Leica DMI6000 B microscope with LAS X 1.5.1.13187 software. 3D-SIM was performed
utilizing the OMX 3D-SIM superresolution system located within the Light Microscopy Imaging Center at
Indiana University Bloomington (https://biochemistry.indiana.edu/labs-facilities/iu-facilities/light-microscopy
.html). The system is equipped with four Photometrics Cascade II electron-multiplying charge-coupled-
device (EMCCD) cameras that permit imaging four colors simultaneously and is controlled by DV-OMX
software. Image processing was completed using the Applied Precision softWoRx software.
Primary antibodies used in this study included rabbit anti-HA (Cell Signaling Technology), rabbit
anti-myc (Cell Signaling Technology), a rabbit polyclonal antibody against the MORN1 protein (49),
mouse monoclonal antibody 5F4 (detects F1B ATPase; P. Bradley, unpublished results), and rabbit
anti-acetyl-K40--tubulin (catalog no. ABT241; EMD Millipore), all used at 1:1,000, with the exception of
5F4 which was used at 1:5,000. Secondary antibodies included Alexa Fluor 594- or Alexa Fluor 488-
conjugated goat anti-rabbit and goat anti-mouse (Invitrogen), all used at 1:2,000.
Phenotypic characterization of mutant and complemented strains. For drug effects on mito-
chondrial morphology, infected HFFs on coverslips were vehicle or drug treated with monensin (1 ng/
ml), atovaquone (100 nM), pyrimethamine (1 M), or myxothiazol (50 ng/ml) for 12 h. To allow for
recovery, drug-containing medium was washed away and replaced with normal growth medium for an
additional 12 h. IFA was performed as described above using F1B ATPase antibodies to monitor the
mitochondrion. Samples were examined in a blind manner, and at least 100 vacuoles per sample were
inspected. Experiments were performed in experimental and biological triplicates.
Plaque and doubling assays were performed with 12-well plates using standard methods (50). Briefly,
for the plaque assays, 500 freshly egressed parasites were added to confluent HFF monolayers. After 4
days of incubation, cultures were fixed with methanol for 5 min and stained with crystal violet. Plaques
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were imaged using a ProteinSimple imaging system, and the number of plaques was counted by using
a light microscope. Experiments were performed in experimental and biological triplicates.
Yeast two-hybrid screen. Yeast two-hybrid (Y2H) screening was performed by Hybrigenics Services,
S.A.S., Paris, France. The coding sequence for Fis1 (amino acids [aa] 2 to 118; GenBank accession no.
XM_018781322.1) was PCR amplified and cloned into pB66 as a C-terminal fusion with the Gal4
DNA-binding domain (Gal4-Fis1). The construct was checked by sequencing and used as a bait to screen
a random-primed Toxoplasma cDNA library constructed in pP6. pB66 derives from the original pAS2ΔΔ
vector (51), and pP6 is based on the pGADGH plasmid (52). Forty-six million clones (5-fold the complexity
of the library) were screened using a mating approach with YHGX13 (Y187 ade2-101::loxP-kanMX-loxP
mat) and CG1945 (mat) yeast strains as previously described (51). A total of 247 His-positive (His)
colonies were selected on a medium lacking tryptophan, leucine, and histidine. The prey fragments of
the positive clones were amplified by PCR and sequenced at their 5= and 3= junctions. The resulting
sequences were used to identify the corresponding interacting proteins in the GenBank database (NCBI)
using a fully automated procedure. A confidence score (predicted biological score [PrBS]) was attributed
to each interaction as previously described (53).
Immunoprecipitation assay. To confirm the results of the yeast two-hybrid screening, we per-
formed one immunoprecipitation assay using RHΔhptHAFis1, with the parental RHΔhpt parasites as a
negative control. Extracellular parasites from 10 T175 culture flasks were spun down, washed twice with
cold PBS, and resuspended in Pierce coimmunoprecipitation (Co-IP) lysis buffer (Thermo Fisher Scientific)
with protease/phosphatase inhibitor cocktail (100, Cell Signaling Technology). After 1 h of lysis at 4°C,
the samples were sonicated three times for 15 s each time, with 1-min rest period between each
sonication. After sonication, samples were pelleted, and the supernatant was transferred to Pierce
anti-HA magnetic beads (Thermo Fisher Scientific). Samples were placed on a rocker at 4°C for 2.5 h
before beads were washed once with Pierce Co-IP lysis buffer and twice with PBS. Beads were
resuspended in 8 M urea and sent for liquid chromatography coupled to tandem mass spectrometry
(LC/MS-MS) analysis. Results were narrowed down to proteins that had at least four peptides in the
RHΔhptHAFis1 sample and none in the RHΔhpt control. This shortened list was then compared to the
list of putative interactors obtained through yeast two-hybrid assay.
Western blots. Extracellular parasites were pelleted and resuspended in 2 Laemmli sample buffer
(Bio-Rad) with 5% 2-mercaptoethanol (Sigma-Aldrich). Samples were boiled for 5 min at 95°C before
separation on a gradient 4 to 20% sodium dodecyl sulfate (SDS)-polyacrylamide gel (Bio-Rad). Samples
were then transferred to nitrocellulose membrane using standard methods for semidry transfer (Bio-Rad).
Membranes were probed with rabbit anti-HA (Cell Signaling Technologies), mouse anti-c-myc (Cell
Signaling Technologies), or mouse anti-SAG1 (Thermo Fisher Scientific) at a dilution of 1:5,000 for 1 h.
Membranes were then washed and probed with either goat anti-mouse horseradish peroxidase or goat
anti-rabbit horseradish peroxidase (Sigma-Aldrich) at a dilution of 1:10,000 for 1 h (GE Healthcare).
Proteins were detected using SuperSignal West Femto substrate (Thermo Fisher) and imaged using the
FluorChem R system (Biotechne). All original Western blots are shown in Data Set S2 in the supplemental
material.
For comparative analysis of LMF1 protein levels in RHΔku80:Fis1ΔTM parasites to the levels in
RHΔku80 parasites, the parasites were centrifuged and washed once with PBS. Parasites were counted
using a hemocytometer, and the parasite pellets were resuspended at appropriate volumes to equilibrate
the concentration of parasites. The subsequent immunoblots were then probed for anti-SAG1 as a
loading control. ImageJ was used for densitometry analysis of the detected protein band and compared
to SAG1 signal. The ratio of LMF1 protein levels (normalized to the SAG1 levels in the same sample) of
RHΔku80:Fis1ΔTM to RHΔku80 parasites was determined and represented as a percentage. These
determinations were done in biological triplicate, and the described percentage is an average of these
replicates.
Statistical analysis. Statistics were performed with either JMP14.0 or Prism software.
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